Skip to main content
Plasmapp Co., Ltd. logo

Plasmapp Co., Ltd. — Investor Relations & Filings

Ticker · 405000 ISIN · KR7405000001 KO Manufacturing
Open in API
Filings indexed 214 across all filing types
Latest filing 2025-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 405000

About Plasmapp Co., Ltd.

https://plasmapp.com/

Plasmapp Co., Ltd. is a company specializing in plasma engineering technology for the medical sector. Originating from the Korea Advanced Institute of Science and Technology (KAIST), the company develops and manufactures advanced plasma-based solutions. Its core offerings include low-temperature plasma sterilizers, such as the STERLINK series, designed for the rapid and safe sterilization of heat-sensitive medical instruments. In addition to sterilization and disinfection, Plasmapp provides technologies for surface treatment and regenerative activation to enhance the safety and efficacy of medical devices, including implants, aiming to improve infection control and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Plasmapp Co., Ltd.' covering the period from January 1, 2025, to June 30, 2025. It contains detailed corporate information, management structure, history, capital changes, and governance details, which are characteristic of a comprehensive interim financial report. It is not a mere announcement or certification, as it provides substantive data regarding the company's operations and financial structure for the specified interim period. H1 2025
2025-08-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership, including convertible bonds and stock holdings, by Kiwoom Securities and its related parties in the company Plasmab. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership changes and thresholds.
2025-07-30 Korean
대표이사변경
Board/Management Information Classification · 1% confidence The document is a formal announcement regarding a change in the company's Chief Executive Officer (CEO). It details the outgoing CEO, the incoming CEO, the reason for the change, and the date of the board resolution. This falls directly under the category of Board/Management Information.
2025-06-20 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제2회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing regarding the 'acquisition of convertible bonds before maturity' (전환사채 발행후 만기전 사채 취득) by the company Plasmab. It details the specific bond series, acquisition amount, acquisition date, and the reason for the acquisition (agreement with bondholders). This type of disclosure relates to changes in the company's capital structure and debt obligations, which falls under the 'Capital/Financing Update' category.
2025-06-13 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Plasmapp' (주식회사 플라즈맵) covering the period from January 1, 2025, to March 31, 2025. It contains detailed business descriptions, product information, financial data (sales, raw materials, production capacity), and management discussions. This aligns with the definition of an Interim/Quarterly Report (IR) as it provides substantive financial and operational analysis for a period shorter than a full fiscal year. Q1 2025
2025-05-15 Korean
주권매매거래정지해제 (감자 주권 변경상장)
Delisting Announcement Classification · 1% confidence The document is a short regulatory notice from the KOSDAQ exchange regarding the lifting of a trading suspension for Plazmap Co., Ltd. due to a capital reduction (reverse stock split) and subsequent relisting. It is a brief, formal regulatory announcement rather than a financial report or a specific corporate action like a dividend or director dealing. As it is a regulatory notice regarding market operations, it falls under the RNS category.
2025-05-02 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.